Scientists Map Heart Failure at Single-Cell Level

Scientists just cracked open a window into heart failure that could change how we treat the world's deadliest condition.

Researchers from University of Utah Health and UC San Diego built the first complete map of gene regulation in failing human hearts, examining more than 750,000 individual cells from 36 people. The detail is stunning: they identified 12 major heart cell types, tracked changes at 50,000 DNA locations, and watched how cells transform as disease takes hold.

The timing matters. Heart failure kills more people worldwide than any other illness, yet doctors have only a handful of proven treatments. The biggest problem isn't lack of medical tools but a shortage of biological targets to aim those tools at.

"Right now, one of the biggest limitations in cardiology is not the lack of tools, but the lack of targets," says Dr. Neil Chi, professor of medicine at UC San Diego. "This kind of data changes that."

The team discovered that failing hearts undergo massive cellular shifts. Muscle cells dwindle while immune cells and scar tissue multiply. More than 10,000 genes change their activity levels as hearts struggle and fail.

The most exciting finding came from tracking cells through intermediate disease states. Muscle cells don't just flip from healthy to diseased overnight. They progress through several in-between stages where the damage actively unfolds.

"If we can understand and target those transitions, we may be able to intervene earlier and more effectively," Chi explains.

The research also solved a genetics puzzle. Most DNA changes linked to heart disease sit in noncoding regions that don't make proteins but control when genes switch on and off. Scientists knew these regions mattered but couldn't figure out how. The new atlas connects specific DNA changes to the exact cell types they affect, particularly heart muscle cells.

Why This Inspires

This breakthrough emerged from an act of generosity. Heart failure patients donated their tissue over many years, hoping their contribution would help others. Dr. Stavros Drakos, who led the Utah team, says fulfilling that hope feels incredible.

The atlas is now available to scientists worldwide as a free resource for discovering new drug targets. Research teams can pinpoint which genes to study, which cell types to focus on, and which disease stages to interrupt.

For patients waiting for better options, this map represents something tangible: a detailed blueprint showing where medicine can intervene next.

"This study provides a roadmap to the landscape of major cardiac cell types of all four chambers of the normal and failing human heart," Drakos says. The findings point to multiple new targets for developing heart failure therapies.

The work transforms how scientists understand disease at its most fundamental level, revealing not just which genes fail but how their regulatory systems collapse across the genome.